The PE Ratio as of October 2024 (TTM) for Lipella Pharmaceuticals Inc. (LIPO) is -0.74

According to Lipella Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.74. This represents a change of -39.84% compared to the average of -1.23 of the last 4 quarters.

Lipella Pharmaceuticals Inc. (LIPO) Historical PE Ratio (quarterly & annually)

How has LIPO PE Ratio performed in the past?

The mean historical PE Ratio of Lipella Pharmaceuticals Inc. over the last ten years is -209.57. The current -0.74 PE Ratio has changed -64.69% with respect to the historical average. Over the past ten years (40 quarters), LIPO's PE Ratio was at its highest in in the March 2023 quarter at 0.28. The PE Ratio was at its lowest in in the June 2021 quarter at -24.17.

Lipella Pharmaceuticals Inc. (LIPO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Lipella Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lipella Pharmaceuticals Inc. (LIPO) Average PE Ratio

How has LIPO PE Ratio performed in the past?

The current PE Ratio of Lipella Pharmaceuticals Inc. (LIPO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Lipella Pharmaceuticals Inc. (LIPO) PE Ratio vs. Peers

How is LIPO’s PE Ratio compared to its peers?

Lipella Pharmaceuticals Inc.’s PE Ratio is less than Senti Biosciences, Inc. (-0.17), less than Fennec Pharmaceuticals Inc. (47.68), greater than Monopar Therapeutics Inc. (-2.81), less than Applied Molecular Transport Inc. (-0.14), less than Adynxx, Inc. (0), less than Ascletis Pharma Inc. (0), greater than Eupraxia Pharmaceuticals Inc. (-64.08), greater than AVAX Technologies, Inc. (-4.58), less than Transgene SA (-0.00), greater than Alpha Cognition Inc. (-6.46), greater than ImmuCell Corporation (-3.43), greater than Anebulo Pharmaceuticals, Inc. (-6.99), greater than NervGen Pharma Corp. (-5.76), greater than Acrivon Therapeutics, Inc. Common Stock (-7.37), greater than Protagenic Therapeutics, Inc. (-4.12), less than Miromatrix Medical Inc. (-0.37), greater than Eliem Therapeutics, Inc. (-3.41), greater than Inhibrx Biosciences, Inc. (-2.42), less than Merrimack Pharmaceuticals, Inc. (0.14), greater than Celcuity Inc. (-8.92), greater than Enliven Therapeutics, Inc. (-7.19), greater than null (-16.26),

Build a custom stock screener for Lipella Pharmaceuticals Inc. (LIPO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lipella Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lipella Pharmaceuticals Inc. (LIPO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lipella Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.